FDA Orange Book
Generic for Frova
Frova contains frovatriptan. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Frova is frovatriptan. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Frova and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Frova products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | EQ 2.5MG BASE | Discontinued | None | 4 | AB |
NDA 021006, held by ENDO OPERATIONS LTD. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic frovatriptan
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| GLENMARK PHARMACEUTICALS LTD | 204730 | AB (A-rated, therapeutically equivalent) | March 11, 2016 | EQ 2.5MG BASE |
| AMNEAL PHARMACEUTICALS CO GMBH | 211292 | AB (A-rated, therapeutically equivalent) | November 6, 2018 | EQ 2.5MG BASE |
| RENATA PLC | 213891 | AB (A-rated, therapeutically equivalent) | April 6, 2022 | EQ 2.5MG BASE |
| LEADING PHARMA LLC | 216998 | AB (A-rated, therapeutically equivalent) | April 16, 2025 | EQ 2.5MG BASE |
Questions
Is there a generic for Frova?
Yes. The generic name for Frova is frovatriptan. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Frova?
The active ingredient in Frova is frovatriptan, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.